Loading…
Suzhou-based biotech/fine-chemicals company; specific product line not established from available knowledge.
Suzhou-based biotech/fine-chemicals company; specific product line not established from available knowledge.
Moat: none
Headquarters: Suzhou, China · Employees: 678
Size Suzhou Highfine Biotech (301393.SZ) is a China Materials company (Chemicals: Major Diversified) with a market value of $865M, the 2591st largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥53.94 on 6 Nov 2026.
Performance Over six months the shares fell 8.3%, against -24.8% for the median peer and -16.4% for the China market (cap-weighted) — 8th highest of 21 in its peer set.
Growth Revenue grew 35.6% over the last twelve months (peer median +3.2%); the operating margin is 17.4% (peer median 10.3%).
Valuation It trades at 32.3× forward earnings against a peer median of 22.2× (5th most expensive of 15).
Capital Return on invested capital runs 2.5 points below its cost of capital (10.5% WACC).
Next results Next results expected around 15 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥757M | CN¥600M | CN¥451M | CN¥388M | CN¥445M |
| Revenue growth | — | +33% | +16% | -13% | — |
| Gross profit | CN¥268M | CN¥194M | CN¥173M | CN¥144M | CN¥189M |
| EBITDA | n/a | CN¥143M | CN¥114M | CN¥92.2M | CN¥154M |
| Net income | CN¥123M | CN¥115M | CN¥134M | CN¥99.0M | CN¥129M |
| Free cash flow | -CN¥373M | -CN¥108M | CN¥29.6M | -CN¥31.1M | CN¥59.1M |
| Capital expenditure | CN¥436M | CN¥211M | CN¥108M | CN¥120M | CN¥81.4M |
| Total debt | CN¥146M | CN¥115M | CN¥17.2M | CN¥13.8M | CN¥28.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 301393.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -14.8% | -15.0% | 10th highest of 21 |
| 6-month return | -8.3% | -24.8% | 8th highest of 21 |
| Distance from 52-week high | -27.8% | -41.8% | 7th highest of 21 |
| Revenue growth (TTM) | +35.6% | +3.2% | 2nd highest of 21 |
| Operating margin | 17.4% | 10.3% | 5th highest of 21 |
| Forward P/E | 32.3× | 22.2× | 5th most expensive of 15 |
| ROIC minus cost of capital | -2.5 pp | -3.0 pp | 10th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Suzhou Highfine Biotech 301393.SZ | China | $865M | -8% | +36% | 17% | 32.3× | n/a | n/a |
| Raghav Productivity Enhancers RPEL.NS | India | $864M | +133% | +38% | 28% | n/a | n/a | n/a |
| Guangzhou Sanfu Newmaterials Technology 688359.SS | China | $870M | -41% | +8% | -7% | n/a | n/a | n/a |
| Polyrocks Chemical 688669.SS | China | $831M | +40% | -8% | -6% | n/a | 35.9% | +15.2% |
| Sanyo Chemical Industries 4471.T | Japan | $823M | +24% | 0% | 10% | 10.5× | -5.1% | -2.5% |
| Jiangxi Hungpai New Material 605366.SS | China | $821M | -47% | +2% | -11% | 236.0× | n/a | n/a |
| Zhejiang Huangma Technology 603181.SS | China | $935M | -30% | +7% | 17% | 14.5× | n/a | n/a |
| Xinyaqiang Silicon Chemistry 603155.SS | China | $788M | -6% | +6% | 10% | 37.0× | 31.1% | +3.9% |
| Hubei Chaozhuo Aviation Technology 688237.SS | China | $776M | +6% | -1% | 1% | 41.5× | 45.3% | +26.0% |
| Jubilant Ingrevia JUBLINGREA.NS | India | $966M | -24% | +15% | 10% | 21.1× | 27.3% | +44.9% |
| Daxin Materials 5234.TW | Taiwan | $767M | -42% | +10% | 19% | 25.7× | 17.7% | +1.5% |
| Jiangsu Zhengdan Chemical Industry 300641.SZ | China | $981M | -28% | -30% | 17% | n/a | 8.8% | +11.6% |
| JCU 4975.T | Japan | $759M | -26% | +2% | 40% | 13.6× | 6.3% | +7.0% |
| Caregen 214370.KS | South Korea | $1.01B | -73% | -8% | 24% | 22.6× | 35.2% | +3.8% |
| KH Neochem 4189.T | Japan | $732M | +20% | -11% | 12% | 12.3× | -5.7% | +8.3% |
| Victrex VCT.L | United Kingdom | $1.04B | +54% | -1% | 14% | 21.7× | 15.7% | +1.9% |
| Liaoning Oxiranchem,Inc 300082.SZ | China | $716M | -39% | +4% | 0% | 35.1× | n/a | n/a |
| Dalian Bio-Chem 603360.SS | China | $1.05B | -55% | 0% | 16% | 23.5× | 9.5% | +18.4% |
| Jiansu Huachang Chemical 002274.SZ | China | $679M | -25% | +9% | -3% | 5.7× | 23.6% | +1.3% |
| Ningxia Zhongke Biotechnology 600165.SS | China | $679M | -19% | +8% | -73% | n/a | n/a | n/a |
| Shandong Sanyuan Biotechnology 301206.SZ | China | $676M | -18% | +15% | 4% | n/a | n/a | n/a |